Gene expression profiling of DMU-212-induced apoptosis and anti-angiogenesis in vascular endothelial cells

Pharmaceutical Biology

Volumn 54, Issue 4, 2016, Pages 660-666

  Miao, Yiming ^a   Cui, Liuqing ^a   Chen, Zhiqiang ^a   Zhang, Lu ^a  

^a HENAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Angiogenesis; microarray; trans 3454 tetramethoxystilbene

Indexed keywords

3,4,5,4' TETRAMETHOXYSTILBENE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; DMU-212;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; AREG GENE; ARTICLE; BCL2L11 GENE; BIRC3 GENE; C1ORF110 GENE; C2CD4B GENE; C2ORF66 GENE; CCL20 GENE; CD274 GENE; CDKN3 GENE; CHSY3 GENE; CONTROLLED STUDY; CREB5 GENE; CSNK1G1 GENE; CXCL1 GENE; CYP1A1 GENE; CYP1B1 GENE; DRUG MECHANISM; DRUG POTENCY; DUSP8 GENE; EGR1 GENE; ERRFI1 GENE; GEM GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HBEGF GENE; HIST1H2BH GENE; HUMAN; HUMAN CELL; IL8 GENE; ITGB8 GENE; KITLG GENE; KRTAP5 2 GENE; LOC151760 GENE; LOC283392 GENE; LOC644714 GENE; MIR31 GENE; MMP10 GENE; MPZL2 GENE; MVK GENE; NEDD9 GENE; PDK4 GENE; PGM5P2 GENE; PLA2G4C GENE; PLAU GENE; RAB23 GENE; SC4MOL GENE; SCARNA4 GENE; SELECTIN E GENE; SLC17A5 GENE; SLC41A2 GENE; SNORA14A GENE; SNORD1142 GENE; SPHK1 GENE; SPRY4 GENE; TCEB3C GENE; TIFA GENE; TMEM217 GENE; TNFAIP3 GENE; TNFSF15 GENE; TNFSF9 GENE; TRPC4 GENE; UMBILICAL VEIN ENDOTHELIAL CELL; VCAM1 GENE; DRUG EFFECTS; ENDOTHELIUM CELL; PHYSIOLOGY; PROCEDURES;

ANGIOGENESIS INHIBITORS; APOPTOSIS; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; STILBENES;

EID: 84960362842     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1071414     Document Type: Article

References (43)

1. Abdullaev IF, Bisaillon JM, Potier M, et al. (2008). Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 103: 1289-99.
2. Alvarez SE, Harikumar KB, Hait NC, et al. (2010). Sphingosine-1- phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 24: 1084-8.
3. Andreyev A, Fiskum G. (1999). Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain versus liver. Cell Death Differ 6: 825-932.
4. Antigny F, Girardin N, Frieden M. (2012). Transient receptor potential canonical channels are required for in vitro endothelial tube formation. J Biol Chem 287: 5917-27.
5. Bair AM, Thippegowda PB, Freichel M, et al. (2009). Tiruppathi C. Ca2+ entry via TRPC channels is necessary for thrombin-induced NF-kappaB activation in endothelial cells through AMP-activated protein kinase and protein kinase. Cdelta. J Biol Chem 2: 563-74.
6. Chemnitz JM, Parry RV, Nichols KE, et al. (2004). SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 173: 945-54.
7. Chen LK, Qiang PF, Xu QP, et al. (2013). trans-3, 4, 5, 40- Tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo. Acta Pharmacol Sin 34: 1174-82.
8. Cong X, Li Y, Lu N, et al. (2014). Resveratrol attenuates the inflammatory reaction induced by ischemia/reperfusion in the rat heart. Mol Med Rep 9: 2528-32.
9. Craig JC, Schumacher MA, Mansoor SE, et al. (2001). Consensus and variant cAMP-regulated enhancers have distinct CREB-binding properties. J Biol Chem 276: 11719-28.
10. Donnahoo KK, Shames BD, Harken AH, et al. (1999). Review article: The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162: 196-203.
11. Francisco LM, Sage PT, Sharpe AH. (2010). The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236: 219-42.
12. Freichel M, Suh SH, Pfeifer A, et al. (2001). Lack of an endothelial storeoperated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice. Nat Cell Biol 3: 121-7.
13. Graziani A, Poteser M, Heupel WM, et al. (2010). Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the vascular endothelium: Evidence for a regulatory TRPC4-beta-catenin interaction. J Biol Chem 285: 4213-23.
14. Hait NC, Allegood J, Maceyka M, et al. (2009). Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 4: 1254-7.
15. Huang DC, Strasser A. (2000). BH3 -Only proteins-essential initiators of apoptotic cell death. Cell 103: 839-42.
16. Jaffe EA, Nachman RL, Becker CG, et al. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-56.
17. Kang Z, Zhu H, Luan H, et al. (2014). Curculigoside A induces angiogenesis through VCAM-1/Egr-3/CREB/VEGF signaling pathway. Neuroscience 267: 232-40.
18. Lee CY, Tsai YT, Loh SH, et al. (2014). Urotensin II induces interleukin 8 expression in human umbilical vein endothelial cells. PLoS One 9: e90278.
19. Lin WY, Chang YC, Lee HT, et al. (2009). CREB activation in the rapid, intermediate, and delayed ischemic preconditioning against hypoxicischemia in neonatal rat. J Neurochem 108: 847-59.
20. Liu ZJ, Tian R, Li Y, et al. (2011). Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin. Ann Surg 254: 450-6.
21. Ma Z, Molavi O, Haddadi A, et al. (2008). Resveratrol analog trans trans-3, 4, 5, 40-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol. Cancer Chemother Pharmacol 63: 27-35.
22. Macdonald SG, Crews CM, Wu L, et al. (1993). Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro. Mol Cell Biol 13: 6615-20.
23. Nagila A, Netsawang J, Suttitheptumrong A, et al. (2013). Inhibition of p38MAPK and CD137 signaling reduce dengue virus-induced TNF-α secretion andapoptosis. Virol J 4: 105.
24. Olas B, Wachowicz B, Stochmal A, et al. (2002). Anti-platelet effects of different phenolic compounds from Yucca schidigera Roezl. bark. Platelets 13: 167-73.
25. Piotrowska H, Myszkowski K, Abraszek J, et al. (2014). DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer. Biomed Pharmacother 68: 397-400.
26. Sale S, Verschoyle RD, Boocock D, et al. (2004). Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans- 3, 4, 5, 40-tetramethoxystilbene. Br J Cancer 90: 736-44.
27. Sasaki A, Taketomi T, Kato R, et al. (2003). Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat Cell Biol 5: 427-32.
28. Schild L, Keilhoff G, Augustin W, et al. (2001). Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria. FASEB J 15: 565-7.
29. Stakleff KS, Sloan T, Blanco D, et al. (2012). Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells. Asian Pac J Cancer Prev 13: 1333-40.
30. Tiruppathi M, Freichel SM, Vogel BC, et al. (2002). Impairment of store-operated Ca2+ entry in TRPC4(-/-) mice interferes with increase in lung microvascular permeability. Circ Res 91: 70-6.
31. Vallabhapurapu S, Karin M. (2009). Regulation and function of NFkappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
32. Valladares A, Alvarez AM, Ventura JJ, et al. (2000). p38 mitogenactivated protein kinase mediates tumor necrosis factor-alphainduced apoptosis in rat fetal brown adipocytes. Endocrinology 141: 4383-95.
33. Walle T, Hsieh F, DeLegge MH, et al. (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-82.
34. Wang H, Zhou H, Zou Y, et al. (2010). Resveratrol modulates angiogenesis through the GSK3b/b-catenin/TCF-dependent pathway in human endothelial cells. Biochem Pharmacol 80: 1386-95.
35. Wang WM, Zhao ZL, Ma SR, et al. (2015). Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor- 1a and notch1 in head neck squamous cell carcinoma. PLoS One 10: e0119723.
36. Wilson-Annan J, O'Reilly LA, Crawford SA, et al. (2003). Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol 162: 877-87.
37. Xia Z, Dickens M, Raingeaud J, et al. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-31.
38. Xu LX, Grimaldo S, Qi JW, et al. (2014). Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis. Int J Biochem Cell Biol 55: 109-18.
39. Yoon YK, Kim HP, Song SH, et al. (2012). Down-regulation of mitogeninducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells. Cancer Lett 316: 77-84.
40. Yu J, Tian S, Metheny-Barlow L, et al. (2001). Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor. Circ Res 89: 1161-7.
41. Yun H, Park S, Kim MJ, et al. (2014). AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. FEBS J 281: 4421-38.
42. Zhu J, Nguyen MT, Nakamura E, et al. (2012). Cre-mediated recombination can induce apoptosis in vivo by activating the p53 DNA damage-induced pathway. Genesis 50: 102-11.
43. Zong WX, Lindsten T, Ross AJ, et al. (2001). BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 15: 1481-6.